ArticleBritish journal of clinical pharmacology2025

Cancer drug applications to the EMA and the FDA: A comparison of new drugs and extension of indication in terms of approval decisions and time in review.

Allan Cramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.